Drug Shortage Report for ADMELOG
| Report ID | 160685 |
| Drug Identification Number | 02469901 |
| Brand name | ADMELOG |
| Common or Proper name | Insulin lispro |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INSULIN LISPRO |
| Strength(s) | 100UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 10 mL vial, 1 vial/box |
| ATC code | A10AB |
| ATC description | INSULINS AND ANALOGUES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-05-25 |
| Actual start date | 2022-06-01 |
| Estimated end date | 2022-08-30 |
| Actual end date | 2022-08-18 |
| Shortage status | Resolved |
| Updated date | 2022-08-26 |
| Company comments | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2022-08-26 | French | Compare |
| v9 | 2022-08-26 | English | Compare |
| v8 | 2022-06-02 | English | Compare |
| v7 | 2022-06-01 | French | Compare |
| v6 | 2022-06-01 | English | Compare |
| v5 | 2022-05-31 | French | Compare |
| v4 | 2022-05-31 | English | Compare |
| v3 | 2022-05-26 | English | Compare |
| v2 | 2022-05-16 | French | Compare |
| v1 | 2022-05-16 | English | Compare |
Showing 1 to 10 of 10